The FDA may be about to change everything for peptide research. Secretary RFK Jr. announced plans to move 14 peptides from Category 2 to Category 1. That means FDA recognized. Potentially prescribable through FDA considers adding a dozen peptides to its bulk drug compounding list RAPS FDA Peptide Reclassification 2026: What It Means for Providers FDA mulls compounding for peptides previously flagged over safety risks BioSpace FDA Peptide Reclassification: What This Means For Weight Loss, Recovery, And More